• Explore /
  • Poster
  • / Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA+P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa).

Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA+P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa).

Abstract Video & Slides Poster

Authors

null

Sean Matthew McBride

Memorial Sloan Kettering Cancer Center, New York, NY

Sean Matthew McBride , Daniel Eidelberg Spratt , Marisa Kollmeier , Wassim Abida , Han Xiao , Susan F. Slovin , Channing Judith Paller , Curtiland Deville , Robert Benjamin Den , Jason W.D. Hearn , Howard I. Scher , Michael J. Zelefsky , Dana E. Rathkopf

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT02772588

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5012)

DOI

10.1200/JCO.2021.39.15_suppl.5012

Abstract #

5012

Abstract Disclosures

Similar Posters

First Author: Bridget F. Koontz

First Author: Nicholas George Nickols

First Author: John Nikitas

First Author: Tian Zhang